Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models
Chemical and Pharmaceutical Bulletin · 2025
DOI: 10.1248/cpb.c25-00389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Akiho Yagi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku,…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bombyx, Mycobacterium smegmatis, Actinobacteria. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
In screening for antibacterial agents from co-cultures of Mycobacterium smegmatis and microbial resources, such as actinomycetes and fungi, the known hydroxyquinone antibiotic griseorhodin A (1) was isolated from a co-culture of actinomycete strain TMPU-20A002 and M. smegmatis. Compound 1 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE), with minimum inhibitory concentrations of 0.25 and 2.0 μg/mL, respectively. In silkworm infection models with MRSA and VRE, 1 exhibited therapeutic efficacy, with ED50 values of 2.5 and 18 μg/larva·g, respectively. A pharmacokinetic analysis of silkworms revealed an elimination half-life of 4.4 h in the hemolymph, indicating a favorable metabolic profile. This is the first in vivo evaluation of griseorhodin A, including its pharmacological activity and metabolic behavior, and it highlights its potential as a candidate for the development of novel antibacterial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
Zitieren
APA
Yagi, A., Sasaki, R., & Uchida, R. (2025). Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00389
Vancouver
Yagi A, Sasaki R, Uchida R. Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00389
BibTeX
@article{Yagi2025,
author = {Yagi, Akiho and Sasaki, Reo and Uchida, Ryuji},
title = {Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/cpb.c25-00389}
}
EUVIMED